Cannabis Law Report

OCTOBER 26, 2021

The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.

Clinical Trials 52

Clinical Trials Sleep Medicine Pharmaceutical 52

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

SpeedWeed

FEBRUARY 18, 2021

The study was carried out by researchers in Israel, who looked at how inhaling herbal cannabis impacted ulcerative colitis patients over a period of eight weeks, with continued, steady, use. The patients also kept taking standard medication. The patients also kept taking standard medication. View original article.

Clinical Trials 52

Clinical Trials Treatment Data THC 52

SpeedWeed

MAY 15, 2021

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. For this study, researchers recruited 90 patients suffering from severe, chronic PTSD. View original article. Image via.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression.

THC 144

THC CBD Clinical Trials Sleep 144

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? We provide free educational resources, including ‘The Answer of the Day,’ a daily question and answer email that reviews the medical marijuana articles published in the peer-reviewed medical journals. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

MMJ Recs

JULY 30, 2024

In this article, we will explore the potential of medical cannabis as a treatment option for individuals diagnosed with PTSD, examining its scientific basis, clinical evidence, controversies, and future implications. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.

Therapy 116

Therapy Treatment Clinical Trials Sleep 116

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Project CBD

NOVEMBER 11, 2023

I have many patients that want to use cannabis, and they who ask me what product should they get? — and this is probably true in Japan, as well — the time allowed for patient visits has gotten smaller and smaller. I teach many patients breathing exercises, simple breath control methods that I find to be very effective.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

MMJ Recs

JULY 9, 2024

Patients often struggle with symptoms that range from physical discomfort to cognitive impairment. In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Veriheal

MAY 3, 2022

Clinical Trial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. We’ll never know for certain whether this article was intentionally designed to scare potential MMJ patients away.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

MARCH 23, 2022

However, our drug laws impede research and deny patients access to these highly effective medicines. These disorders include severe depression, anxiety and depression occurring in terminal cancer patients, alcohol and nicotine dependence, and PTSD (post-traumatic stress disorder). Secondly, people report being healed.

Clinical Trials 52

Clinical Trials Treatment Medicine Access 52

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. The authors note, however, that the data doesn’t include patient outcomes. Read their full article at . The findings were published today in Frontiers in Pharmacology.

Medicine 52

Medicine Clinical Trials Sleep Data 52

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana for HIV/AIDS offers a promising complementary treatment for patients.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

MedicalJane

MAY 21, 2020

A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. The team’s article , “The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model,” is published in the journal Life, Volume 10, Issue 5.

Oil 100

Oil Hemp Extraction Clinical Trials 100

LifeCannMD

FEBRUARY 1, 2022

In this article, you’ll learn why and how medical marijuana is effective for treating OCD. As a result, these patients often experience high levels of stress, anxiety, and depression. Medical Marijuana for a Patient with OCD. This is a great option in Florida for OCD-diagnosed individuals. What Exactly Does OCD Mean?

Marijuana 98

Marijuana Clinical Trials Patients Therapy 98

United Patients Group

JANUARY 8, 2023

In order to get involved in research, you can look up clinical trials in your area that may be accepting volunteers. The post Cannabis and the Immune System appeared first on United Patients Group. The time is ripe for more research on this front, especially as more countries move towards legalizing medical marijuana.

Blood Pressure 122

Blood Pressure Sleep Cannabinoids Clinical Trials 122

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. While research is ongoing, some patients have reported remarkable improvements in their seizure control when using MMJ. Some patients have shared their experiences with using MMJ to manage their condition.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. These compounds may help reduce symptoms and improve the quality of life for patients.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

The Joint Blog

APRIL 21, 2020

For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. There is moderate-quality evidence that chronic and acute administration of CBD can improve psychotic symptoms in schizophrenia patients.”

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

MMJ Recs

JULY 11, 2024

Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers.

Sleep 111

Sleep Treatment Research and Development Therapy 111

The Joint Blog

APRIL 16, 2020

The study is published in the Journal of Medical Imaging and Radiation Sciences and titled Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials. “Most patients want to learn more about cannabis from their healthcare team, but most oncology professionals feel too uninformed to make recommendations. .”

Therapy 63

Therapy Clinical Trials Patients Cannabinoids 63

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. Mental Health Challenges.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Healer

DECEMBER 17, 2021

In this article I’ll explain how and why these interactions occur and describe the classes of medications that are processed by the same liver enzymes the body uses to process CBD. Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

JULY 9, 2021

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 81

Law Therapy Clinical Trials Research and Development 81

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

JULY 6, 2021

Bankole Johnson was featured in a March 5 th 2021 Forbes article, “Dr. Johnson, DSc, MD, MPhil, FRCPsych said, “I am pleased to join the Ehave Medical Advisory Board and look forward to working towards bringing psychedelic-assisted therapies to patients experiencing substance use issues. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

MAY 31, 2022

In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium— producing non-psychoactive mushroom supplements. The first path, that of traditional medicine, currently offers patients limited options. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Project CBD

FEBRUARY 28, 2023

9 In a February 2021 article in Nutritional Outlook , Jesse Karagianes, vice president of sales of the CBD natural products company CV Sciences (San Diego, California), was quoted as saying: “[T]he single largest factor which contributed to slow category sales was the deluge of inferior products hitting the market. 2020;12(7):1935.

CBD 144

CBD Seed-To-Sale Food Access 144

SpeedWeed

AUGUST 11, 2021

This will be the second clinical trial to give cannabis medicine or placebos to participating military veterans, and according to the Chief Science Officer of the MAPS Public Benefit Corporation, Berra Yazar-Klosinki, PhD, the first trial was a great success. “We View original article. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

MMJ Recs

AUGUST 14, 2024

Over time, medical marijuana for managing neuropathic pain has gained attention as an encouraging alternative, thanks to the positive outcomes many patients have experienced. This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research.

Nerve Pain 96

Nerve Pain Marijuana Strains Chronic Pain 96

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”. View original article.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

United Patients Group

JANUARY 5, 2023

In this article, I’ll explain how taking probiotics might make you less likely to catch a cold or flu—or at least keep your symptoms from getting worse when you do get sick. A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu.

Digestion 105

Digestion Research and Development Food Strains 105

Cannabis Law Report

AUGUST 2, 2021

Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”. For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see these Radicle Resources articles. Eric Schudiske, eric@s2spr.com.

CBD 81

CBD Data Sleep Clinical Trials 81

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52